5 patient evaluations for Abacavir-lamivudine (ABC/3TC) with a adherence rating of Always

35 members have decided to share their profiles only with other members of PatientsLikeMe.

Jun 23, 2014 (Started Feb 21, 2013)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 600 mg-300 mg Daily

  • 0 helpful marks

Feb 13, 2009 (Started Dec 01, 2005)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 600 mg-300 mg Daily
Cost: < $25 monthly
Side effects: fatigue

  • 0 helpful marks

Nov 5, 2008 (Started Jan 01, 2005)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 600 mg-300 mg Daily

  • 0 helpful marks

Oct 10, 2008 (Started Jul 03, 2005)

  • Effectiveness
    Major (for Increase effect of another treatment)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 600 mg-300 mg Daily

Oct 4, 2008 (Started Jul 03, 2005)

  • Effectiveness
    Major (for Increase effect of another treatment)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 600 mg-300 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.

  • 0 helpful marks

Sep 2, 2008 (Started May 08, 2007)

  • Effectiveness
    Moderate (for fatigue)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 600 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 5 of 5 patient evaluations for Abacavir-lamivudine (ABC/3TC)